Lobbying disclosures · Lobbying report
VRTX: second_quarter 2026 lobbying report
A lobbying activity report was filed. Income and expenses are separate reporting measures and must not be added together.
Follow VRTX- Became public
- Jul 20, 2026, 7:21 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 3:38 PM EST
Why this is connected
Legal-name match: VERTEX PHARMACEUTICALS INCORPORATED is VERTEX PHARMACEUTICALS INC / MA (https://www.sec.gov/Archives/edgar/data/875320/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/68bf48b2-6ff9-4700-a71a-56347a36f5a4/","filing_uuid":"68bf48b2-6ff9-4700-a71a-56347a36f5a4","filing_type":"Q2Y","filing_type_display":"2nd Quarter - Report (No Activity)","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/68bf48b2-6ff9-4700-a71a-56347a36f5a4/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Claire P. Kaiser, Senior Managing Director","dt_posted":"2026-07-20T19:21:13-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"900 17th Street, NW","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401103585,"url":"https://lda.gov/api/v1/registrants/401103585/","house_registrant_id":null,"name":"MCLARTY INBOUND LLC","description":"​Advises foreign entities on doing business in the US","address_1":"900 17th Street, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CLAIRE P. KAISER","contact_telephone":"+1 202-419-1420","dt_updated":"2026-07-30T08:55:35.342941-04:00"},"client":{"id":65435,"url":"https://lda.gov/api/v1/clients/65435/","client_id":65435,"name":"VERTEX PHARMACEUTICALS INCORPORATED","general_description":"Biotechnology company","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-03-12"},"lobbying_activities":[],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in VRTX
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Sep 5, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
Sold Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Aug 26, 2026 · disclosed Sep 5, 2026
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Bought Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- Feb 2, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
Sold Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 2, 2026
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
Bought Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Oct 23, 2024 · disclosed Jan 13, 2026 · filed 447 days later
- Sep 12, 2025$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Aug 26, 2025 · disclosed Sep 12, 2025 · Dependent
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.